Accelerated diagnostic protocols using high-sensitivity troponin assays to rule in or out myocardial infarction: A systematic review

Jonie J. Hsiao, Manuel A. Celedon, James L. Rudolph, Kristin J. Konnyu, Sebhat A. Erqou, Muhammad Baig, Thomas A. Trikalinos, Kyari Sumayin Ngamdu, Ghid Kanaan, Sunny Cui, Thien Phuc Tran, Taylor Rickard, Ethan M. Balk, Eric Jutkowitz

Research output: Contribution to journalArticlepeer-review

Abstract

Background Accelerated diagnostic protocols (ADPs) that incorporate high-sensitivity cardiac troponin (hs-cTn) can help emergency department (ED) providers quickly rule in or out acute myocardial infarction (AMI). Objectives This systematic review evaluated the effectiveness and comparative effectiveness of clinically applied ADPs that use hs-cTn on clinical and health service use outcomes. Methods Medline, Embase, ClinicalTrials.gov, and the Cochrane Database of Systematic Reviews were searched through May 2022. Standard systematic review methods were followed. Results We found 17 eligible primary studies (reporting on 23 ADPs), including 2 randomized controlled trials (N = 32,050), 5 nonrandomized comparative studies (N = 18,377) and 10 single-group studies (N = 44,016). One study compared an ADP with hs-cTn to hs-cTn alone, finding that the ADP increased discharges from the ED to the community and is not associated with worse clinical outcomes. Among 6 studies, ADPs with shorter compared to longer hs-cTn timing and ADPs that incorporated the HEART score compared to the TIMI score reduced ED length of stay and increased discharges to the community without resulting in worse clinical outcomes. Across studies, ADPs that measured hs-cTn for up to 12 h had longer ED lengths of stay than ADPs with ≤6 h of measurements. Conclusions ADPs with shorter compared to longer hs-cTn timing reduce ED length of stay, increase discharges, and are not associated with changes in 30-day major adverse cardiovascular event, AMI, or mortality. Among ADPs that reduce ED length of stay, there is no obvious best choice, and any ADP should be tailored to local context.
Original languageEnglish
Article number100086
JournalJEM Reports
Early online date14 Mar 2024
DOIs
Publication statusE-pub ahead of print - 14 Mar 2024

Bibliographical note

Funding
This report was prepared by the Evidence Synthesis Program Center located at the Providence VA Health Care System, directed by Eric Jutkowitz, PhD and James L. Rudolph, MD, and funded by the Department of Veterans Affairs, Health Services Research and Development.

The findings and conclusions in this document are those of the author(s) who are responsible for its contents and do not necessarily represent the views of the Department of Veterans Affairs or the United States government. Therefore, no statement in this article should be construed as an official position of the Department of Veterans Affairs. No investigators have any affiliations or financial involvement (e.g., employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties) that conflict with material presented in the report.

Acknowledgments
The authors are grateful to Gaelen Adam, MLIS for literature searching.

Keywords

  • Hs-cTn
  • Myocardial infarction
  • Emergency department
  • Accelerated diagnostic protocol

Fingerprint

Dive into the research topics of 'Accelerated diagnostic protocols using high-sensitivity troponin assays to rule in or out myocardial infarction: A systematic review'. Together they form a unique fingerprint.

Cite this